得益於產量的增加和有效的成本管理 艾默生電氣(EMR.US)二季度業績超預期
格隆匯5月4日丨受通脹和供應鏈壓力的影響,艾默生電氣(EMR.US)週三公佈了高於預期的上季度業績。公司利潤為6.74億美元,高於上年同期的5.61億美元;每股收益為1.13美元,高於去年同期的每股93美分;銷售額增長8%達到47.9億美元,高於分析師預計的47.1億美元。該公司表示,由於全球需求強勁,自動化解決方案業務增長了17%。艾默生首席執行官Lal Karsanbhai表示,利潤增長得益於產量的增加和有效的成本管理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.